CD86 and COVID-19: Furthermore, the persistent downregulation of CD86 and upregulation of PD-L1 expression in cDCs correlated with COVID-19 severity and could be associated with a reduced capacity to activate ‘naïve’ and memory Th cells in peripheral lymphoid tissue [33].